Multiple Receptors for the Pancreatic Polypeptide (PP-Fold) Family: Physiological Implications

Experimental Biology and Medicine

Volumn 218, Issue 1, 1998, Pages 7-22

  Gehlert, Donald R ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE RECEPTOR; NEUROPEPTIDE Y; PANCREAS POLYPEPTIDE; PEPTIDE YY;

GASTROINTESTINAL TRACT; HUMAN; INTESTINE INNERVATION; MOLECULAR BIOLOGY; NONHUMAN; PANCREAS; PROTEIN FAMILY; SHORT SURVEY;

EID: 0031957139     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-218-44263     Document Type: Article

References (182)

1. Kimmel JR, Pollock HG, Hazelwood RL. Isolation and characterization of chicken insulin. Endocrinology 83:1323-1330, 1968.
2. Lin T-M, Chance RE. Gastrointestinal actions of a new bovine pancreatic peptide (BPP). In: Chey and Brooks, Ed. Endocrinology of the Gut. Thorofare, NJ: Charles B. Slack, Inc., 1974.
3. Tatemoto K. Isolation and characterization of peptide YY (PYY), a candidate gut hormone that inhibits pancreatic exocrine function. Proc Natl Acad Sci USA 79:2514-2418, 1982.
4. Tatemoto K, Carlquist M, Mutt V. Neuropeptide Y - a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 296:659-660, 1982.
5. Tatemoto K, Neuropeptide Y. Complete amino acid sequence of the brain peptide. Proc Natl Acad Sci USA 79:5485-5489, 1982.
6. DiMaggio DA, Chronwall BM, Buchman K, O'Donohue TL. Pancreatic polypeptide immunoreactivity in rat brain is actually neuropeptide Y. Neuroscience 15:1149-1157, 1985.
7. Allen YS, Adrain TE, Allen JM, Tatemoto K, Crow J, Bloom SR, Polak JM. Neuropeptide Y distribution in the rat brain. Science 221:877-879, 1983.
8. Chronwall BM, Dimaggio DA, Massari VJ, Pickel VM, Ruggerio DA, O'Donohue TL. The anatomy of neuropeptide Y-containing neurons in the rat brain. Neuroscience 15:1159-1181, 1985.
9. O'Donohue TL, Chronwall BM, Pruss RM, Mezey E, Kiss JZ, Eiden LE, Massari VJ, Tessel RE, Pickel VM, Dimaggio DA, Hotchkiss AJ, Crowley WR, Zukowska-Grojec Z. Neuropeptide Y and peptide YY in neuroneal and endocrine systems. Peptides 6:755-768, 1985.
10. Blundell TL, Pitts JE, Tickle IJ, Wood SP, Wu C-W. X-ray analysis (1.4 Å resolution) of avian pancreatic polypeptide: small globular protein hormone. Proc Natl Acad Sci USA 78:4175-4179, 1981.
11. Hazelwood RL. The pancreatic polypeptide (PP-fold) family: Gastrointestinal, vascular, and feeding behavioral implications. Proc Soc Exp Biol Med 202:44-63, 1993.
12. Larhammar D. Evolution of neuropeptide Y. peptide YY and pancreatic polypeptide. Reg Pep 62:1-11, 1996.
13. Wahlestedt C, Yanaihara N, Håkanson R. Evidence for different pre and postjunctional receptors for neuropeptide Y and related peptides. Regul Pept 13:307-318, 1986.
14. Wahlestedt C, Edvinsson L, Ekblad E, Håkanson R. Effects of neuropeptide Y at sympathetic neuroeffector junctions: existence of Y1-and Y2-receptors. In: Nobin, Owman and Arneklo-Nobin, Ed. Neuroneal Messengers in Vascular Function. Amsterdam: Elsevier, 1987.
15. 1 receptor agonist. Proc Natl Acad Sci USA 87:182-186, 1990.
16. 34]neuropeptide Y selectively identifies postjunctional-mediated actions of neuropeptide Y in vivo in rats and dogs. Eur J Pharmacol 193:15-19, 1991.
17. Westlind-Danielsson A, Unden A, Abens J, Andell S, Bartfai T. Neuropeptide Y receptors and the inhibition of adenylate cyclase in the human frontal and temporal cortex. Neurosci Lett 74:237-242, 1987.
18. McDermott BJ, Millat BC, Piper HM. Cardiovascular effects of neuropeptide Y. receptor interactions and cellular mechanisms. Cardiovascular Res 27:893-905, 1993.
19. 2+ increases in vascular smooth muscle cells. FEBS Lett 259:79-82, 1989.
20. 1 receptors for neuropeptide Y are coupled to the mobilization of intracellular calcium and inhibition of adenylate cyclase. FEBS Lett 260:73-78, 1990.
21. Eva C, Keinänen K, Monyer H, Seeburg P, Sprengel R. Molecular cloning of a novel G protein-coupled receptor that may belong to the neuropeptide receptor family. FEBS Lett 271:80-84, 1990.
22. Larhammar D, Blomquist AG, Yee F, Jazin E, Yoo H, Wahlestedt C. Cloning and functional expression of a human neuropeptide Y/peptide Y Y receptor of the Y1 subtype. J Biol Chem 267:10935-10938, 1992.
23. Herzog H, Hort YJ, Ball HJ, Haves G, Shine J, Selbie LA. Cloned human neuropeptide Y receptor couples to two different second messenger systems. Proc Natl Acad Sci USA 89:5794-5798, 1992.
24. Herzog H, Hort YJ, Shine J, Selbie LA. Molecular cloning, characterization, and localization of the human homolog to the reported bovine NPY Y3 receptor: lack of NPY binding and activation. DNA Cell Biol 12:465-471, 1993.
25. Larsen PJ, Sheikh SP, Jakobsen CR, Schwartz TW, Mikkelsen JD. Regional distribution of putative NPY Y1 receptors and neurons expressing Y1 mRNA in forebrain areas of the rat central nervous system. Eur J Neurosci 5:1622-1637, 1993.
26. Hinson J, Rauh C, Coupet J. Neuropeptide Y stimulates inositol phospholipid hydrolysis in rat brain miniprisms. Brain Res 446:379-382, 1988.
27. 3 receptor subtype. Mol Brain Res 26:320-324, 1994.
28. 2 receptors. Biopolymers (Peptide Sci) 37:123-142, 1995.
29. Dumont Y, Fournier A. St-Pierre S, Quirion R. Comparative characterization and autoradiographic distribution of neuropeptide Y receptor subtypes in the rat brain. J Neurosci 13:73-86, 1993.
30. 125I-labelled peptide YY binding sites in the rat brain. Neurochem Int 21:45-67, 1992.
31. 2 receptor radioligands. Synapse 22:139-158, 1996.
32. Gehlert DR, Gackenheimer SL. Differential distribution of neuropeptide Y Y1 and Y2 receptors in the rat and guinea pig brain. Neuroscience 76:215-224, 1996.
33. 125I]Bolton-Hunter neuropeptide Y binding sites in the forebrain of various mammalian species. Brain Res 419:403-407, 1987.
34. Daniels AJ, Mathews JE, Slepetis RJ, Jansen M, Viveros OH, Anjaneyulu A, Harrington W, Heyer D, Landavazo A, Leban JJ, Spaltenstein A. High-affinity neuropeptide Y receptor antagonists. Proc Natl Acad Sci USA 92:9067-9071, 1995.
35. Gehlert DR, Schober DA, Beavers L, Gadski R, Hoffmann JA, Smiley DL, Chance RE, Lundell I, Larhammar D. Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor. Mol Pharmacol 50:112-118, 1996.
36. Doods HN, Wieland HA, Engel W, Eberlein W, Willim K-D, Entzeroth M, Wienen W, Rudolf K. BIBP 3226, the first selective neuropeptide Y1 receptor antagonist: A review of its pharmacological properties. Regul Peptides 65:71-77, 1996.
37. Serradeil-Le Gal C, Valeet G, Rouby PE, Pellet A, Oury-Donat F, Brossard G, Lespy L, Marty E, Neliat G, de Cointet P, Maffrand JP, LeFur G. SR120819 A, an orally active and selective neuropeptide Y Y1 receptor antagonist. FEBS Lett 362:192-196, 1995.
38. Sautel M, Rudolf K, Wittneben H, Herzog H, Martinez R, Munoz M, Eberlein W, Engel W, Walker P, Beck-Sickinger AG. Neuropeptide Y and the nonpeptide antagonist BIBP3226 share an overlapping binding site at the human Y1 receptor. Mol Pharmacol 50:285-292, 1996.
39. 1 receptors. Eur J Pharmacol 33:275-284, 1997.
40. Foucart S, Majewski H. Pertusis toxin does not affect neuropeptide Y action on rat heart. Naunyn-Schmeideberg Arch Pharmacol 340:658-665, 1989.
41. Colmers WF, Pittman QJ. Presynaptic inhibition by neuropeptide Y and baclofen in hippocampus: insensitivity to pertusis toxin treatment. Brain Res 489:99-104, 1989.
42. 2+ channels in sensory neurons. Proc Natl Acad Sci USA 85:3633-3637, 1988.
43. Bleakman D, Harrison NL, Colmers WF, Miller RJ. Investigations into neuropeptide Y-mediated presynaptic inhibition in cultured hippocampal neurons of the rat. Br J Pharmacol 107:334-340, 1992.
44. Wiley JW, Gross RA, MacDonald RL. Agonists for neuropeptide Y receptor subtypes NPY-1 and NPY-2 have opposite actions on rat nodose neuron calcium currents. J Neurophysiol 70:324-330, 1993.
45. Toth PT, Bindokas VP, Bleakman D, Colmers WF, Miller RJ. Mechanism of presynaptic inhibition by neuropeptide Y at sympathetic nerve terminals. Nature 364:635-639, 1993.
46. Wahlestedt C, Håkanson R. Effects of neuropeptide Y (NPY) at the sympathetic neuroeffector junction. Can pre and post junctional receptors be distinguished? Med Biol 64:85-88, 1986.
47. Stjernquist M, Owman C. Further evidence for a prejunctional action of neuropeptide Y on cholinergic motor neurons in the rat uterine cervix. Acta Physiol Scand 138:95-96, 1990.
48. Grundemar L, Grundström N, Johansson IGM, Andersson RGG, Håkanson R. Suppression by neuropeptide Y of capsaicin-sensitive sensory nerve-mediated contraction in guinea pig airways. Br J Pharmacol 99:473-476, 1990.
49. Gehlert DR, Beavers L, Johnson D, Gackenheimer SL, Schober DA, Gadski RA. Expression cloning of a human brain neuropeptide Y Y2 receptor. Mol Pharm 49:224-228, 1996.
50. Gerald C, Walker MW, Vaysse PJ-J, He C, Branchek TA, Weinshank RL. Expression cloning and pharmacological characterization of a human hippocampal neuropeptideY/peptide YY Y2 receptor subtype. J Biol Chem 270:26758-26761, 1995.
51. Rose PM, Fernandes P, Lynch JS, Frazier ST, Fisher SM, Kodukula K, Kienzle B, Seethala R. Cloning and expression of a cDNA encoding a human type 2 neuropeptide Y receptor. J Biol Chem 270:22661-22664, 1995.
52. Rimland JM, Seward EP, Humbert Y, Ratti E, Trist DG, North RA. Coexpression with potassium channel subunits used to clone the Y2 receptor for neuropeptide Y. Mol Pharmacol 49:387-390, 1996.
53. McQuiston AR, Colmers WF. Neuropeptide Y2 receptors inhibit the frequency of spontaneous but not miniature EPSCs in CA3 pyramidal cells of rat hippocampus. J Neurophysiol 76:3159-3168, 1996.
54. Grouzmann E, Buclin T, Martire M, Cannizzaro C, Dorner B, Rasaname A, Mutter M. Characterization of a selective antagonist of neuropeptide Y at the Y2 receptor. J Biol Chem 272:7699-7706, 1997.
55. Grundemar L, Wahlstedt C, Reis DJ. Neuropeptide Y acts at an atypical receptor to evoke cardiovascular depression and to inhibit glutamate responsiveness in the brainstem. J Pharmacol Exp Therap 258:633-638, 1991.
56. Grundemar L, Wahlstedt C, Reis DJ. Long-lasting inhibition of the cardiovscular responses to glutamate and the baroreceptor reflex elecited by neuropeptide Y injected into the nucleus tractus solitarius. Neurosci Lett 122:135-139, 1991.
57. Glaum SR, Miller RJ, Rhim H, Maclean D, Georgic LM, MacKenzie RG, Grundemar L. Characterization of Y3 receptor mediated synaptic inhibition by chimeric neuropeptide Y-peptide YY peptides in the rat brainstem. Br J Pharmacol 120:481-487, 1997.
58. Balasubramaniam A, Sheriff S, Rigel DF, Fischer JE. Characterization of neuropeptide Y binding in rat cardiac ventricular membranes. Peptides 11:545-550, 1990.
59. Wahlestedt C, Regunathan S, Håkanson R. Identification of cultured cells selectively expressing Y1-, Y2-, or Y3-type receptors for neuropeptide Y/peptide YY. Life Sci 50:PL7-PL14, 1992.
60. Higuchi H, Costa E, Yang W-Y. Neuropeptide Y inhibits the acetylcholine-mediated release of catecholamines from bovine adrenal chromaffin cells. J Pharmacol Exp Ther 244:468-474, 1988.
61. Monnet FP, Dubonnel G, de Montigny C. Neuropeptide Y selectively potentiates N-methyl-d-aspartate-induced neuroneal activation. Eur J Pharmacol 182:207-208, 1990.
62. McQuiston AR, Colmers WF. Neuropeptide Y does not alter NMDA conductances in CA3 pyramidal neurons: a slice-patch study. Neurosci Lett 138:261-264, 1992.
63. Lundell I, Blomqvist AG, Berglund M, Schober DA, Johnson D, Statnick MA, Gadski R, Gehlert DR, Larhammar D. Cloning of a human receptor of the NPY receptor family with high affinity for pancreatic polypeptide and peptide YY. J Biol Chem 270:29123-29128, 1995.
64. Bard JA, Walker MW, Branchek TA, Weinshank RL. Cloning and functional expression of a human Y4 subtype receptor for pancreatic polypeptide, neuropeptide Y and peptide YY. J Biol Chem 270:26762-26765, 1995.
65. Lundell I, Statnick MA. Johnson D, Schober DA, Starbäck P, Gehlen DR, Larhammar D. The cloned rat pancreatic polypeptide receptor exhibits profound differences to the orthologus human receptor. Proc Natl Acad Sci 93:5111-5115, 1996.
66. 34-PYY is a high affinity radioligand for rat PP. 1 and Y1 receptors: Evidence for heterogeneity in pancreatic polypeptide receptors. Peptides 18:397-401, 1997.
67. Gerald C, Walker MW, Criscone L, Gustafson EL, Batzl-Hartmann C, Smith K, Vaysse P, Durkin MM, Laz TM, Linemeyer DL, Schaffhauser AO, Whitebread S, Hofbauer KG, Table I Branchek TA, Weinshank RL. A receptor subtype involved in neuropeptide-Y-induced food intake. Nature 382:168-171, 1996.
68. Hu Y, Bloomquist BT, Cornfield LJ, DeCarr LB, Flores-Riveros JR, Friedman L, Jiang P, Lewis-Higgins L, Sadlowski Y, Schaefer J, Velazquez N, McCaleb ML. Identification of a novel hypothalamic neuropeptide Y receptor associated with feeding behavior. J Biol Chem 271:26315-26319, 1996.
69. Gerald CP, Walker MW, Branchek T, Weinshank RL. Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptideY/peptide YY receptor (Y5). Intenational Publication Number., 1996.
70. Weinberg DH, Sirinathsinghji DJS, Tan CP, Shiao L-L, Morin N, Rigby MR, Heavens RH, Rapoport DR, Bayne ML, Cascieri MA, Strader CD, Linemeyer DL, MacNeil DJ. Cloning and expression of a novel neuropeptide Y receptor. J Biol Chem 271:16435-16438, 1996.
71. Gregor P, Feng Y, DeCarr LB, Cornfield LJ, McCaleb ML. Molecular characterization of a second mouse pancreatic polypeptide receptor and its inactivated human homolog. J Biol Chem 271:27776-27781, 1996.
72. Matsumoto M, Nomura T, Momose K, Ikeda Y, Kondou Y, Akiho H, Togami J, Kimura Y, Okada M, Yamaguchi T. Inactivation of a novel neuropeptide Y/peptide YY receptor gene in primate species. J Biol Chem 271:27217-27220, 1996.
73. Laburthe M, Chenut B. Rouyer-Fessard C, Tatemoto K, Couvineau A, Servin A, Amiranoff B. Interaction of peptide YY with intestinal epithelial plasma membranes: Binding of the radioiodinated peptide. Endocrinology 118:1910-17., 1986.
74. Castan I, Valet P, Voisin T, Quideau N, Laburthe M, Lafontan M. Identification and functional studies of a specific peptide YY-preferring receptor in dog adipocytes. Endocrinology 131:1970-76., 1992.
75. Castan I, Valet P, Larrouy D, Voisin T, Remaury A, Daviaud D, Laburthe M, Lafontan M. Distribution of PYY receptors in human fat cells: an antilipolytic system alongside the α-adenergic system. Am J Physiol 265:E74-E80, 1993.
76. Voisin T, Bens M, Cluzeaud F, Vandewalle A, Laburthe M. Peptide YY receptors in the proximal tubule PKSV-PCT cell line derived from transgenic mice. J Biol Chem 268:20547-20554, 1993.
77. t 44 000 glycoprotein. J Biol Chem 266:10762-10767, 1991.
78. Holliday ND, Cox HM. Stably transfected neuropeptide U Y-1 receptors exhibit a PYY-preferring phenotype when expressed in a human colonic epithelial cell line. Br J Pharmacol 120:P290, 1997.
79. Lin TM, Chance RE. Spectrum of gastrointestinal actions of bovine, PP. In: Bloom, Ed. Gut Hormones. London, U.K. Churchill Livingston, 1978.
80. Lin TM, Evans DC, Chance RE, Spray GF. Bovine pancreatic polypeptide: Action on gastric and pancreatic secretion in dogs. Am J Physiol 232:E311-E315, 1977.
81. Hazelwood RL. Biosynthesis chemistry, storage of islet (endocrine) products. In: Hadley, Ed. The Endocrine Pancreas. Eaglewood Cliffs, NJ. Prentice Hall, 1989.
82. Louie DS, Williams JA, Owyang C. Action of pancreatic polypeptide on rat pancreatic secretion: In vivo and in vitro. Am J Physiol 249:G489-G495, 1985.
83. Grossman MI, Brown JC, Said S, Adelson J, Rothman SS, Kin T, Chance RE, Gerring EL, Gregory H, Crentzfeldt W, Kokas E, Nasset ES, Sasaki H, Falona GR, Unger RH, Andersen S, Thompson JC, Glass GBJ. Candidate hormones of the gut. Gastroenterology 67:730-755, 1974.
84. Clark JT, Kalra PS, Crowley WR, Kalra SP. Neuropeptide Y and human pancreative polypeptide stimulate feeding behavior in rats. Endocrinology 115:427-429, 1984.
85. Trinh T, Dumont Y, Quirion R. High levels of specific neuropeptide Y/pancreatic polypeptide receptors in the rat hypothalamus and brainstem. Eur J Pharmacol 318:R1-R3, 1996.
86. Souli A, Chariot J, Voisin T, Presset O, Tsocas A, Balasubramaniam A, Laburthe M, Roze C. Several receptors mediate the antisecretory effect of peptide YY, neuropeptide Y, and pancreatic polypeptide on VIP-induced fluid secretion in the rat jejunum in vivo. Peptides 18:551-557, 1997.
87. Voisin T, Rouyer-Fessard C, Laburthe M. Distribution of common peptide YY-neuropeptide Y receptor along rat intestinal villus-crypt axis. Am J Physiol 258:G753-G759, 1990.
88. Ekman R, Wahlestedt C, Bottcher G, Sundler F, Håkanson R, Panula P. Peptide YY-like immunoreactivity in the central nervous system of the rat. Regul Pept 16:157-168, 1986.
89. Broomé M, Hökfelt T, Terenius L. Peptide YY (PYY) immunoreactive neurons in the lower brainstem and spinal cord of the rat. Acta Physiol Scand 125:349-352, 1985.
90. Grundemar L, Hãkanson R. Multiple neuropeptide Y receptors are involved in cardiovascular regulation. Peripheral and central mechanisms. Gen Pharmacol 24:785-796, 1993.
91. de Quidt ME, Emson PC. Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system II. Immunohislochemical analysis. Neuroscience 18:545-618, 1986.
92. Pernow J, Lundberg JM, Kauser L, Hjemdahl P, TheodorssonNorheim E, Martinsson E, Pernow B. Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man. Clin Physiol 6:561-578, 1986.
93. Shaw C, Cormican K, Thim L, Maule AG, Sloan JM, Buchanan KD. Neuropeptide Y and neuropeptide Y 3-36: isolation from human pancreatic endocrine tumors. Regul Pept 45:387-394, 1993.
94. Grandt D, Schimiczek M, Rascher W, Feth F, Shively J, Lee TD, Davis MT, Reeve JR, Michel MC. Neuropeptide Y 3-36 is an endogenous ligand selective for Y2 receptors. Regul Pept 67:33-37, 1996.
95. Eberlein GA, Eysselein VE, Schaeffer M, Layer P, Grandt D, Goebell H, Niebel W. A new molecular for of PYY. sturctural characterization of human PYY (3-36) and PYY (1-36). Peptides 10:797-803, 1989.
96. Grundemar L, Wahlestedl C, Shen SH, Zukowska-Grojec Z, Håkanson R. Biphasic blood pressure response to NPY in anesthetized rats. Eur J Pharmacol 179:83-87, 1990.
97. Grundemar L, Håkanson R. Neuropeptide Y, peptide YY and C-terminal fragments release histamine from rat peritoneal mast cells. Br J Pharmacol 104:101-103, 1991.
98. Shen GH, Grundemar L, Zukowska-Grojec Z, Håkanson R, Wahlestedt C. C-terminal neuropeptide-Y fragments are mast cell-dependent vasodepressor agents. Eur J Pharmacol 204:249-256, 1991.
99. Dacey RJ, Bassett JE, Takayasu M. Vasomotor responses of rat intracerebral arterioles to vasoactive intestinal peptide, substance P, neuropeptide Y, and bradykinin. J Cereb Blood Flow Metab 8:254-261, 1988.
100. Tseng CJ, Robertson D, Light RT, Atkinson JR, Robertson RM. Neuropeptide Y is a vasoconstrictor of human coronary arteries. Am J Med Sci 296:11-16, 1988.
101. Maturi MF, Greene R, Speir E, Burrus C, Dorsey LM, Markle DR, Maxwell M, Schmidt W, Goldstein SR, Patterson RE. Neuropeptide Y, A peptide found in human coronary arteries constricts primarily small coronary arteries to produce myocardial ischemia in dogs. J Clin Invest 83:1217-1224, 1989.
102. Wahlestedt C, Edvinsson L, Ekblad E, Håkanson R. Neuropeptide Y potentiates norepinephrine-evoked vasoconstriction: mode of action. J Pharmacol Exp Therap 234:735-741, 1985.
103. Dahlöff C, Dahlöff P, Lundberg JM. Neuropeptide Y (NPY): Enhancement upon α-adrenoceptor activation and direct pressor effect in pithed rats. Eur J Pharmacol 109:289-292, 1985.
104. Ekblad E, Edvinsson L, Wahlestedt C, Uddman R, Håkanson R. Neuropeptide Y coexists and co-operates with norepinephrine in perivascular fibres. Regul Pept 8:225-235, 1984.
105. Grundemar L, Mörner J, Högestätt E, Wahlestedt C, Håkanson R. Characterization of vascular receptors for neuropeptide Y. Br J Pharmacol 105:45-50, 1992.
106. Erlinge D, Edvinsson L, Brunkwall J, Yee F, Wahlestedt C. Human neuropeptide Y Y1 receptor antisense oligodeoxynucleotide specifically inhibits neuropeptide Y-evoked vasoconstriction. Eur J Pharmacol 240:77-80, 1993.
107. Sun XY, Zhao XH, Erlinge D, Edvinsson LF, Wahlestedt C, Hedner T. Effects of phosphorothioacted neuropeptide Y Y1-receptor antisense oligodeoxynucleotide in conscious rats and in human vessels. Br J Pharmacol 118:131-136, 1996.
108. Sheikh SP, Roach E, Fuhlendorff J, Williams JA. Localization of Y1 receptors for NPY and PYY on vascular smooth muscle cells in rat pancreas. Am J Physiol 260:G250-G257, 1991.
109. Wharton J, Gordon L, Byrne J, Herzog H, Selbie L, Moore K, Sullivan MHF, Elder MG, Moscoso G, Taylor KM, Shine J, Polak JM. Expression of the human neuropeptide tyrosine Y1 receptor. Proc Natl Acad Sci USA 90:687-691, 1993.
110. Pernow J, Lundberg JM. Neuropeptide Y induces potent contraction of arterial vascular smooth muscle via an endothelium-independent mechanism. Acta Physiol Scand 134:157-158, 1988.
111. Lundberg JM, Torssel L, Sollevi S, Pernow J, Theodorsson Norheim E, Anggard A. Neuropeptide Y and sympathetic vascular control in man. Regul Pept 13:41-52, 1985b.
112. Ullman B, Franc-Cereceda A, Hulting J, Lundberg JM, Saollevi A. Elevation of plasma neuropeptide Y-like immunoreactivity and norepinephrine during myocardial ischemia in man Int Med 228:583-589, 1990.
113. Aizawa Y, Satoh M, Aizawa M, Funazaki T, Niwano S, Miyajima S, Shibata A. Potency and receptors involved in coronary vasoconstriction caused by neuropeptide Y (NPY). Jpn Heart J 28:891-898, 1987.
114. Shigeri Y, Fujimoto M. Neuropeptide Y stimulates DNA synthesis in vascular smooth muscle cells. Neurosci Lett 149:19-22, 1993.
115. Zukowska-Grojec Z, Pruszczyk P, Colton C, Yao J, Shen GH, Myers AK, Wahlestedt C. Mitogenic effect of neuropeptide Y in rat vascular smooth muscle cells. Peptides 14:263-268, 1993.
116. Grundemar L, Håkanson R. Effects of various neuropeptide Y/peptide YY fragments on electrically evoked contractions of the rat vas deferens. Br J Pharmacol 100:190-192, 1990.
117. Lundberg JM, Hemsen A, Larsson O, Rudehill A, Saria A, Fredholm BB. Neuropeptide Y receptor in pig spleen: binding characteristics, reduction of cyclic AMP formation and calcium antagonist inhibition of vasoconstriction. Eur J Pharmacol 145:21-29, 1988.
118. Tessel RE, Miller DW, Misse GA, Dong X, Doughty MB. Characterization of vascular postsynaptic neuropeptide Y receptor function and regulation. 1. NPY-induced constriction in isolated rat femoral artery rings is mediated by both Y1 and Y2 receptors: evidence from benextramine protection studies. J Pharmacol Exp Ther 265:172-177, 1993.
119. Fuxe K, Härfstrand A, Agnati LF, Kalia M, Fredholm B, Svensson T, Gustafsson JA, Lang R, Ganten D. Central catecholamine-neuropeptide Y interactions at the pre and postsynaptic level in cardiovascular centers. J Cardiovasc Pharmacol S1-S13, 1987.
120. 1 receptor agonist. Brain Res 621:126-132, 1993.
121. 13-36. Acta Physiol Scand 141:279-280, 1991.
122. 2 subtype of NPY receptors. J Cardiovasc Pharmacol 21:720-724, 1993.
123. Lundberg JM, Pernow J, Tatemoto K, Dahlof C. Pre- and postjunctional effects of NPY on sympathetic control of rat femoral artery. Acta Physiol Scand 123:511-513, 1985.
124. Jorgensen JC, Fuhlendorff J, Schwartz TW. Structure-function studies on neuropeptide Y and pancreatic polypeptide-evidence for two, PP. -fold receptors in vas deferens. Eur J Pharmacol 186:105-114, 1990
125. 2 type. Eur J Pharmacol 230:231-234, 1993.
126. Colmers WF, Lukowiak K, Pittman QJ. Neuropeptide Y action in the rat hippocampal slice: site and mechanism of presynaptic inhibition. J Neurosci 8:3827-3837, 1988
127. 2 receptor. Br J Pharmacol 102:41-44, 1991.
128. 2 receptor. Br J Pharmacol 103:1781-1789, 1991.
129. Erickson JC, Hollopeter G, Palmiter RD. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science 274:1704-1707, 1996.
130. Aubert JF, Burnier M, Waeber J, Nussberger J, Dipette DJ, Bums JF, Brunner HR. Effect of nonpressor doses neuropeptide Y on cardiac output, regional blood flow distribution and plasma renin, vasopressin and catecholamine levels. J Pharmacol Exp Ther 224:1109-1115, 1988.
131. Saavedra JM, Cruciani R. Quantitative autoradiographic localization of neuropeptide Y (NPY) binding sites in the rat posterior pituitary. Cell Mol Neurobiol 8:333-338, 1990.
132. 125I]-peptide YY binding sites in the human pituitary. Peptides 15:651-656, 1994.
133. Kalra SP, Crowley WR, Neuropeptide Y. A novel neuroendocrine peptide in the control of pituitary hormone secretion and its relation to luteinizing hormone. Front Neuroendocrinol 13:1-46, 1992.
134. Sahu A, Kalra SP. Neuropeptidergic regulation of feeding behavior neuropeptide Y. Trends Endocrinol Metab 4:217-224, 1993.
135. Stanley BG, Magdalin W, Seirafi A, Thomas WJ, Leibowitz SF. The perifornical area: the major focuss of (a) patchily distributed hypothalamic neuropeptide Y-sensitive feeding system (s). Brain Res 604:304-317, 1993.
136. Stanley BG, Magdalin W, Seirafi A, Nguyen MM, Leibowitz SF. Evidence for neuropeptide Y mediation of eating produced by food deprivation and for a variant of the Y1 receptor mediating this peptide's effect. Peptides 13:581-587, 1992.
137. Benchekroun MT, St-Pierre S, Fournier A, Cadieux A. Antagonism of the inhibitory action of neuropeptide Y (NPY) in guinea-pig trachea by the C-terminal fragment NPY (2-36). Br J Pharmacol 109:902-904, 1993.
138. Kalra SP, Dube MG, Fournier A, Kalra PS. Structure-function analysis of stimulation of food intake by neuropeptide Y. effects of receptor agonists. Physiol Behav 50:5-9, 1991.
139. Jolicoeur FB, Michaud JN, Menard D, Fournier A. In vivo structure activity study supports the existence of heterogeneous neuropeptide Y receptors. Brain Res Bull 26:309-311, 1991.
140. Mikkelsen JD, Larsen PJ. A high concentration of NPY (Y1) -receptor mRNA-expressing cells in the hypothalamic arcuate nucleus. Neuroscience Lett 148:195-198, 1992.
141. 125I-neuropeptide Y as a novel radioligand for neuropeptide Y receptors. Soc For Neuroscience Abstracts 19:727, 1993.
142. Kalra SP, Dube MG, Kalra PS. Continuous intraventricular infusion of neuropeptide Y evokes episodic food intake in satiated female rats: effects of adrenalectomy and cholecystokinin. Peptides 9:723-728, 1988.
143. Stanley BG, Lanthier D, Chin AS, Leibowitz SF. Suppression of neuropeptide Y-elicited eating by adrenalectomy or hypophysectomy: reversal with corticosterone. Brain Res 501:32-36, 1989.
144. Beck B, Stricker-Krongrad A, Nicolas JP, Burlet C. Chronic and continuous intracerebroventricular infusion of neuropeptide Y in Long-Evans rats mimics the feeding behavior of obese Zucker rats. Int J Obes 16:295-302, 1992.
145. Paez X, Myers RD. Insatiable feeding evoked in rats by recurrent perfusion of neuropeptide Y in the hypothalamus. Peptides 12:609-616, 1991.
146. Zarjevski N, Cusin I, Vettor R, Rohner-Jeanrenaud F, Jeanrenaud B. Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology 133:1753-1758, 1993.
147. Berrettini WH, Kaye WH, Gwirtsman H, Allbright A. Cerebrospinal fluid peptide YY immunoreactivity in eating disorders. Neuropsychobiol 19:121-124, 1988.
148. Kaye WH, Berrettini WH, Gwirtsman H, George DT. Altered cerebrospinal fluid neuropeptide Y and peptide YY immunoreactivity in anorexia and bulimia nervosa. Arch Gen Psychiatry 47:548-556, 1990.
149. Gehlert DR, Heiman M. Obesity: leptin - neuropeptide Y interactions in the control of body weight. Annu Reports Med Chem 32:21-30, 1997.
150. Campfield LA, Smith FJ, Bum P. The OB protein (leptin) pathway - A link between adipose tissue mass and central neural networks. Hormone Metab Res 28:619-632, 1996.
151. Stephens TW, Basinski M, Bristow PK, Bue-Valleskey JM, Burgett SG, Craft L, Hale J, Hoffmann J, Hsiung HM, Kriauciunas A, MacKellar W, Rosteck J, Schoner B, Smith D, Tinsley FC, Heiman M. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 377:530-532, 1995.
152. Rohner-Jeanrenaud F, Cusin I, Sainsbury A, Zakrzewska KE, Jeanrenaud B. The loop system between neuropeptide Y and leptin in normal and obese rodents. Horm Metab Res 28:642-648, 1996.
153. Heilig M. Neuropeptide Y in releation to behavior and psychiatric disorders: some animal and clinical observations. In: Colmers and Wahlstedt, Ed. The biology of neuropeptide Y and related peptides. Totowa, NJ. Humana, 1993.
154. Heilig M, McLeod S, Brot M, Heinrichs SC, Menzaghi F, Koob GF, Britton KT. Anxiolytic-like action of neuropeptide Y. Mediation by Y1 receptors in amygdala, and dissociation from food intake effects. Neuropsychopharmacology 8:357-363, 1993.
155. Wahlestedt C, Pich EM, Koob GF, Yee F, Heilig M. Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxy-nucleotides. Science 259:528-531, 1993.
156. Kask A, Rago L, Harro J. Anxiogenic-like effect of the neuropeptide Y Y1 receptor antagonist BIBP3226: antagonism with diazepam. Eur J Pharmacol 317:R3-R4, 1996.
157. Heilig M, Wahlestedt C, Widerlöv E. Neuropeptide Y (NPY) -induced suppression of activity in the rat: evidence for NPY receptor heterogeneity and for interaction with alpha-adrenoceptors. Eur J Pharmacol 157:205-213, 1988.
158. Widdowson PS. Quantitative receptor autoradiography demonstrates a differential distribution of neuropeptide-Y Y1 and Y2 receptor subtypes in human
159. Widerlöv E, Helig M, Ekman R, Wahlstedt C. Possible relationship between neuropeptide Y (NPY) and major depression: evidence from huamn and animal studies. Nord J Psychiatry 42:131-137, 1988.
160. Widerlöv E, Lindstrom LH, Wahlestedt C, Ekman R. Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively. J Psychiatr Res 22:69-79, 1988.
161. Widdowson PS, Ordway GA, Halaris AE. Reduced neuropeptide Y concentrations in suicide brain. J Neurochem 59:73-80, 1992.
162. Heilig M, Wahlstedt C, Ekman R, Widerlov E. Antidepressant drugs increase the concentration of neuropeptide Y (NPY) -like immunoreactivity in the rat brain. Eur J Pharmacol 147:465-467, 1988.
163. Bellmann R, Sperk G. Effects of antidepressant drug treatment on levels of NPY or prepro-NPY-mRNA in the rat brain. Neurochem Int 22:183-187, 1993.
164. Heilig M, Widerlov E. Neurobiology and clinical aspects of neuropeptide Y. Crit Rev Neurobiol 9:115-136, 1995.
165. Clark JT, Kalra PS, Kalra SP. Neuropeptide Y stimulates feeding but inhibits sexual behavior in rats. Endocrinology 117:2435-2442, 1985.
166. Kalra SP, Clark JT, Sahu A, Dube MG, Kalra PS. Control of feeding and sexual behaviors by neuropeptide Y. physiological implications. Synapse 2:254-257, 1988.
167. Morris YA, Crews D. The effects of exogenous neuropeptide Y on feeding and sexual behavior in the red-sided garter snake (Thamnophis sirtalis parietalis). Brain Res 530:339-341, 1990.
168. Clark JT, Sahu A, Mrotek JJ, Kalra SP. Sexual function and neuropeptide Y levels in selected brain regions in male spontaneously hypertensive rats. Am J Physiol 261:R1234-R1241, 1991.
169. Beck B, Burlet A, Nicolas JP, Burlet C. Hypothalamic neuropeptide Y (NPY) in obese Zucker rats: implications in feeding and sexual behaviors. Physiol Behav 47:449-553, 1990.
170. Clark JT. Benextramine, a putative neuropeptide Y receptor antagonist, attenuates the termination of receptivity. Physiol Behav 52:965-969, 1992.
171. Poggioli R, Vergoni A-V, Marrama D, Giuliani D, Bertolini A. NPY-induced inhibition of male copulatory activity is a direct behavioral effect. Neuropeptides 16:169-172, 1990.
172. Kalra SP, Fuentes M, Fournier A, Parker SL, Crowley WR. Involvement of the Y-1 receptor subtype in the regulation of luteinizing hormone secretion by neuropeptide Y in rats. Endocrinology 130:3323-3330, 1992.
173. Flood JF, Hernandez EN, Morley JE. Modulation of memory processing by neuropeptide Y. Brain Res 421:280-290, 1987.
174. Flood JF, Morley JE. Dissociation of the effects of neuropeptide Y on feeding and memory: evidence for pre and postsynaptic mediation. Peptides 10:963-966, 1989.
175. Flood JF, Baker ML, Hemandez EN, Morley JE. Modulation of memory processing by neuropeptide Y varies with brain injection site. Brain Res 503:73-82, 1989.
176. Woldbye DP, Larsen PJ, Mikkelsen JD, Klemp K, Madsen TM, Bolwig TG. Powerful inhibition of kainic acid induced seizures by neuropeptide Y via Y5-like receptors. Nat Med 3:761-764, 1997.
177. Vezzani A, Schwarzer C, Lothman EW, Williamson J, Sperk G. Functional changes in somatostatin and neuropeptide Y containing neurons in the rat hippocampus in chronic models of limbic seizures. Epilepsy Res 26:267-279, 1996.
178. Narváez JA, Aguirre JA, Fuxe K. Subpicomolar amounts of NPY (13-36) injected into the nucleus tractus solitarius of the rat counteract the cardiovascular responses to I-glutamate. Neurosci Lett 151:182-186, 1993.
179. Barraco RA, Ergene E, Dunbar JC, Ganduri YL, Anderson GF. Y2 receptors for neuropeptide Y in the nucleus of the solitary tract mediate depressor responses. Peptides 12:691-698, 1991.
180. Herzog H, Hort Y, Schneider R, Shine J. Seminalplasmin: recent evolution of another member of the neuropeptide Y gene family. Proc Natl Acad Sci USA 92:594-598, 1995.
181. Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D, Rivier C, Rivier J, Sawchenko PE, Vale W. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 378:287-292, 1995.
182. Zhang X, Bao L, Xu ZQ, Kopp J, Arvidsson U, Eide R, Hokfelt T. Localization of neuropeptide Y Y1 receptors in the rat nervous system with special reference to somatic receptors on small dorsal root ganglion neurons. Proc Natl Acad Sci USA 91:11738-11742, 1994.